Cart
sales@molnova.com
Lucidenic acid D2
CAS No. 98665-16-8
Lucidenic acid D2( —— )
Catalog No. M31702 CAS No. 98665-16-8
Lucidenic acid D2 is a nartural product from G. lucidum AF.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 859 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLucidenic acid D2
-
NoteResearch use only, not for human use.
-
Brief DescriptionLucidenic acid D2 is a nartural product from G. lucidum AF.
-
DescriptionLucidenic acid D2 is a nartural product from G. lucidum AF.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number98665-16-8
-
Formula Weight514.6
-
Molecular FormulaC29H38O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
RF-amide peptide, Dr...
RF-amide peptide, Drosophila
-
Methyl 3,4,5-trimeth...
Methyl 3,4,5-trimethoxycinnamate may protect the heart from arrhythmias via its inhibitory effect on calcium channel.
-
L-Asparaginase
L-Asparaginase (L-?ASNase), a hydrolase that catalyzes the conversion of L-asparagine, used in acute lymphoblastic leukemia treatment.Asparaginase is an enzyme that is used as a medication. As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin.
